Retinoid X receptor and c-erbA/thyroid hormone receptor regulate erythroid cell growth and differentiation

被引:25
作者
Bartunek, P [1 ]
Zenke, M [1 ]
机构
[1] Max Delbruck Ctr Mol Med, D-13122 Berlin, Germany
关键词
D O I
10.1210/mend.12.9.0173
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nuclear receptors are important regulators of erythroid cell development. Here we investigated the impact of retinoid X receptor (RXR), retinoic acid receptor (RAR), and of the c-erbA/thyroid hormone (T-3) receptor (c-erbA/TR) on growth and differentiation of erythroid cells using an in vitro culture system of stem cell factor-dependent erythroid progenitors. RXR, RAR, and c-erbA/TR-specific ligands were found to induce erythroid-specific gene expression and to accelerate erythroid differentiation in culture, with T-3 being most effective. Furthermore, while ligand-activated c-erbA/TR accelerated differentiation, unliganded c-erbA/TR effectively blocked differentiation and supported sustained progenitor growth in culture. Thus, c-erbA/TR appears to act as a binary switch affecting erythroid cell fate: unliganded c-erbA/TR supports growth while ligand-activated c-erbA/TR induces differentiation. Additionally, to determine the impact of RXR for erythroid cell development, dominant interfering mutant RXRs, lacking the transcriptional activator functions AF-1 and AF-2, or AF-2 only, or the entire DNA-binding domain, were introduced into erythroid progenitor cells via recombinant retrovirus vectors and analyzed for RXR-specific effects. It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells. In marked contrast, expression of the dominant interfering Delta DNA-binding domain RXR, containing a deletion of the entire DNA-binding domain, was incompatible with erythroid cell growth in vitro, suggesting a pivotal role of RXR for erythroid cell development.
引用
收藏
页码:1269 / 1279
页数:11
相关论文
共 63 条
  • [41] Nuclear receptors in Sicily: All in the famiglia
    Perlmann, T
    Evans, RM
    [J]. CELL, 1997, 90 (03) : 391 - 397
  • [42] V-ERB A, NUCLEAR HORMONE RECEPTORS, AND ONCOGENESIS
    PRIVALSKY, ML
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1114 (01) : 51 - 62
  • [43] RASCLE A, 1994, ONCOGENE, V9, P2853
  • [44] RETINOIC ACID RECEPTOR-BETA - IMMUNODETECTION AND PHOSPHORYLATION ON TYROSINE RESIDUES
    ROCHETTEEGLY, C
    GAUB, MP
    LUTZ, Y
    ALI, S
    SCHEUER, I
    CHAMBON, P
    [J]. MOLECULAR ENDOCRINOLOGY, 1992, 6 (12) : 2197 - 2209
  • [45] A CONSERVED C-TERMINAL SEQUENCE THAT IS DELETED IN V-ERBA IS ESSENTIAL FOR THE BIOLOGICAL-ACTIVITIES OF C-ERBA (THE THYROID-HORMONE RECEPTOR)
    SAATCIOGLU, F
    BARTUNEK, P
    DENG, T
    ZENKE, M
    KARIN, M
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (06) : 3675 - 3685
  • [46] DEPLETION OF L-3,5,3'-TRIIODOTHYRONINE AND L-THYROXINE IN EUTHYROID CALF SERUM FOR USE IN CELL-CULTURE STUDIES OF THE ACTION OF THYROID-HORMONE
    SAMUELS, HH
    STANLEY, F
    CASANOVA, J
    [J]. ENDOCRINOLOGY, 1979, 105 (01) : 80 - 85
  • [47] Identification of TRACs (T-3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors
    Sande, S
    Privalsky, ML
    [J]. MOLECULAR ENDOCRINOLOGY, 1996, 10 (07) : 813 - 825
  • [48] REPRESSION OF TRANSCRIPTION MEDIATED AT A THYROID-HORMONE RESPONSE ELEMENT BY THE V-ERB-A ONCOGENE PRODUCT
    SAP, J
    MUNOZ, A
    SCHMITT, J
    STUNNENBERG, H
    VENNSTROM, B
    [J]. NATURE, 1989, 340 (6230) : 242 - 244
  • [49] SCHROEDER C, 1992, ONCOGENE, V7, P203
  • [50] SCHROEDER C, 1990, ONCOGENE, V5, P1445